Tag: Health Canada
-
InnoCan Pharma’s (CSE: INNO) investment potential in the Pharmaceuticals Sector: A Balanced View
InnoCan Pharma Corporation, trading on the Canadian Securities Exchange under the symbol INNO, FSE: IP4, and OTC: INNPF, is a pharmaceutical technology company that has garnered attention in the investment community. This article evaluates its potential as an investment option in the pharmaceuticals space, considering both its recent achievements and challenges. Business Model and Strategic…
-
Lophos Holdings (MESC.C) is selling peyote soon, and you didn’t even know
Lophos Holdings (MESC.C) is a Canadian public company – the only public company – specifically focused on the quickly liberalizing psychedelics sub-sector of Peyote and Mescaline. You may be sitting back in your chair now thinking, “Well hello there,” and I’m with you. For most of my life, peyote was a thing we did with…
-
Today’s Idea: Filament Health (FH.NE) Gaining Traction
Problematic Psychedelics? Psychedelics and mental health treatment go together like orange juice and toothpaste. That’s what I would have said five years ago. Prior to the publication of multiple peer-reviewed studies, I adamantly believed psychedelics would melt your brain. In retrospect, that belief is just about as bogus as going to hell for premarital hand-holding.…
-
Filament Health (FH.NEO): fighting the good fight against anxiety and depression
You’d be hard pressed to find someone who hasn’t been touched by depression or anxiety. Biochemically, they’re considered co-morbid, which means they often happen at the same time and feed off of one another. Depression and anxiety often overlap in terms of neurotransmitters and therefore, they’re often lumped together and treated the same way. And…
-
Filament Health (FH.NEO) brings an all natural option to fight depression and anxiety
You’d be hard pressed to find someone who hasn’t been touched by depression or anxiety. Biochemically, they’re considered co-morbid, which means they often happen at the same time and feed off of one another. Depression and anxiety often overlap in terms of neurotransmitters and therefore, they’re often lumped together and treated the same way. And…
-
Pure Extracts Technologies (PULL.C) pushes on and shows no pandemic fatigue
In the times of yore before COVID-19 sent us scurrying back to our caves for self-reflection and Overlook Hotel style shenanigans, the brass here at Equity Guru sent me on a mission to the snowy wastes of Pemberton, British Columbia. The company I was visiting was Pure Extracts Technologies (PULL.C), a cannabis and hemp biomass…
-
Medexus Pharmaceuticals (MDP.T) gets the Health Canada official nod to commercialize treosulfan
Medexus Pharmaceuticals (MDP.T) received Health Canada’s Notice of Compliance to commercialize treosulfan today, according to a press release. Treosulfan will be sold in Canada using the brand name Trecondyv®. It’s used in combination with another drug called fludarabine as part of a conditioning treatment prior to allogeneic hemapoietic stem cell transplantation. The treatment clears the…
-
Algernon Pharmaceuticals (AGN.C) gets ethical green light for human trials for COVID-19 fighter Ifenprodil
The scientific process isn’t exactly what you were taught in grade 4. There’s a lot more to it, owing to some historical—well, let’s call them what they are—atrocities, which have taken place as long as white lab-coats have been all the rage in knowledge-defining circles. This process is expensive in both time and money and…
-
Q&A: Good Questions from 5 of Equity Guru’s 50,000 monthly readers
No-one likes a braggart – but in Equity Guru’s first four years we’ve represented 120 clients while our website traffic has grown to 50,000 unique monthly readers. During that time, we’ve called three market corrections, issued multiple code-red investor alerts, while recently launching a website devoted to the nascent mushroom/psychedelics industry, and another website devoted…
-
CannTrust (TRST.T) burns $77 million of illegal weed
While Canadian investors digested their Thanksgiving turkey, CannTrust (TRST.T) announced that it has “destroyed approximately $12 million of biological assets and approximately $65 million worth of inventory that was not authorized by CannTrust’s licence,” bring the total value of the torched product to $77 million”. Although the Toronto Stock Exchange was closed for the Canadian…